Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

BioLineRx Falls Most in 2 Weeks, Narrows Gap With U.S. Stock

Feb. 7 (Bloomberg) -- BioLineRx Ltd. slid the most in almost two weeks, narrowing the gap with the biophamaceutical company’s American depositary receipts.

The shares slumped 11 percent, the most since Jan. 26, to 1.66 shekels, or the equivalent of 45 cents, at the 4:30 p.m. close in Tel Aviv. The company’s ADRs, each representing 10 shares, closed at $4.44 yesterday in New York.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.